NCT02298153: A Study of Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (ECHO-110) |
|
|
| Terminated | 1 | 29 | US | atezolizumab, MPDL3280A, epacadostat, INCB024360 | Incyte Corporation, Hoffmann-La Roche, Genentech, Inc. | NSCLC (Non-small Cell Lung Carcinoma), UC (Urothelial Cancer) | 11/17 | 11/17 | | |
